Mechanisms of Fibrogenesis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Experimental biology and medicine

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3181/0707-MR-190PMID 18222966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Myofibroblast: one function, multiple origins

  2010cited by this paper
• Tissue Renewal and Repair: Regeneration, Healing, and Fibrosis

  2010cited by this paper
• Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.

  2007cited by this paper
• Ito cells are liver-resident antigen-presenting cells for activating T cell responses.

  2007cited by this paper
• The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair.

  2007cited by this paper
• TGF-β signaling in vascular fibrosis

  2007cited by this paper
• A proximal activator of transcription in epithelial-mesenchymal transition.

  2007cited by this paper
• Vitamin A-storing cells (stellate cells).

  2007cited by this paper
• p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway

  2007cited by this paper
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells.

  2007cited by this paper
• Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice

  2007cited by this paper
• Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway.

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• Fibrocytes: a new insight into kidney fibrosis.

  2007cited by this paper
• Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1

  2007cited by this paper
• Understanding the biology of angiogenesis: review of the most important molecular mechanisms.

  2007cited by this paper
• The role of CXC chemokines in pulmonary fibrosis.

  2007influential reference
• Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

  2007cited by this paper
• Biliary epithelial‐mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis

  2007cited by this paper
• Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis.

  2007influential reference
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007influential reference
• Transforming growth factor-β and fibrosis

  2007cited by this paper
• Transforming growth factor-beta and fibrosis.

  2007cited by this paper
• VEGF Signaling Through NADPH Oxidase-Derived ROS

  2007influential reference
• TGF-beta signaling in vascular fibrosis.

  2007cited by this paper
• Formation and function of the myofibroblast during tissue repair.

  2007influential reference
• The role of circulating fibrocytes in fibrosis

  2006cited by this paper
• Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions.

  2006cited by this paper
• Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis

  2006cited by this paper
• Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

  2006influential reference
• Hepatic stellate cells and the reversal of fibrosis

  2006cited by this paper
• TGF-beta/Smad signaling in the injured liver.

  2006cited by this paper
• Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle‐like cells regulated by myocardin involved in hypoxia‐induced pulmonary vascular remodelling

  2006cited by this paper
• The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.

  2006influential reference
• Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)

  2006cited by this paper
• Toward a unified theory of renal progression.

  2006cited by this paper
• Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.

  2006cited by this paper
• Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

  2006cited by this paper
• Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis

  2006cited by this paper
• Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.

  2006cited by this paper
• Fas‐associated phosphatase‐1 promotes Fas‐mediated apoptosis in human colon cancer cells: Novel function of FAP‐1

  2006cited by this paper
• Epithelial origin of myofibroblasts during fibrosis in the lung.

  2006cited by this paper
• Targeted therapy for systemic sclerosis.

  2006cited by this paper
• Conversion

  2006cited by this paper
• The epithelial–mesenchymal transition: new insights in signaling, development, and disease

  2006influential reference
• TGF-β/Smad Signaling in the Injured Liver

  2006influential reference
• The bone marrow functionally contributes to liver fibrosis.

  2006cited by this paper
• Evidence for epithelial-mesenchymal transitions in adult liver cells.

  2006cited by this paper
• Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

  2006cited by this paper
• Hepatocyte growth factor: new arsenal in the fights against renal fibrosis?

  2006cited by this paper
• Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling.

  2006cited by this paper
• NADPH Oxidases in the Kidney

  2006cited by this paper
• Reversal of hepatic fibrosis — Fact or fantasy?

  2006cited by this paper
• Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

  2006cited by this paper
• The renal cortical fibroblast in renal tubulointerstitial fibrosis.

  2006cited by this paper
• Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.

  2006cited by this paper
• Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Anti-inflammatory properties of drugs acting on the renin-angiotensin system.

  2005cited by this paper
• Perspective Article: Tissue repair, contraction, and the myofibroblast

  2005cited by this paper
• Effect of extracellular matrix on proliferation and differentiation of porcine lens epithelial cells

  2005cited by this paper
• The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

  2005cited by this paper
• The fallacy of epithelial mesenchymal transition in neoplasia.

  2005cited by this paper
• Regulation of lung injury and repair by Toll-like receptors and hyaluronan

  2005cited by this paper
• In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.

  2005cited by this paper
• NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells

  2005cited by this paper
• The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis.

  2005cited by this paper
• Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts

  2005cited by this paper
• Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.

  2005cited by this paper
• Fibrosis research : methods and protocols

  2005cited by this paper
• Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282)

  2005cited by this paper
• CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

  2005cited by this paper
• Antimicrobial proteins act as "alarmins" in joint immune defense.

  2004cited by this paper
• Regulation of PDGF and its receptors in fibrotic diseases.

  2004cited by this paper
• Integrin (cid:1) V 6 -mediated activation of latent TGF- (cid:2) requires the latent TGF- (cid:2) binding protein-1

  2004cited by this paper
• Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

  2004cited by this paper
• Bone marrow-derived progenitor cells in pulmonary fibrosis.

  2004cited by this paper
• TGF‐β signaling and the fibrotic response

  2004cited by this paper
• New insights into TGF-β–Smad signalling

  2004cited by this paper
• Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal

  2004cited by this paper
• A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.

  2004cited by this paper
• New insights into TGF-beta-Smad signalling.

  2004cited by this paper
• Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1

  2004cited by this paper
• The role of epithelial-to-mesenchymal transition in renal fibrosis

  2004influential reference
• Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal.

  2004cited by this paper
• CCN proteins: multifunctional signalling regulators.

  2004influential reference
• Liver fibrosis

  2004influential reference
• The role of apoptosis in pulmonary fibrosis.

  2004cited by this paper
• Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells.

  2003cited by this paper
• Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.

  2003cited by this paper
• NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

  2003cited by this paper
• In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats

  2003cited by this paper
• Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition.

  2003cited by this paper
• Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

  2003cited by this paper
• Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis

  2003cited by this paper

• Hepatic Stellate Cell-derived IL-11 Exacerbates Liver Fibrosis via Interplay between HSCs and Macrophages

  2026cites this paper
• Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate

  2025cites this paper
• Regulation of Hepatic Stellate Cell Phenotypes in MASH.

  2025cites this paper
• Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitis

  2025cites this paper
• CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms

  2025cites this paper
• SOX9: a key transcriptional regulator in organ fibrosis

  2025cites this paper
• Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary Intervention

  2025cites this paper
• HNF-1α promotes urethral fibrosis by up-regulating STAT3 transcriptional activity in mice hypospadias.

  2025cites this paper
• Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis

  2025cites this paper
• Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration.

  2025cites this paper
• The immunopathophysiology of organ fibrosis: From mechanisms to immunotherapies.

  2025cites this paper
• Long non-coding RNA MALAT1: A crucial factor in fibrotic diseases

  2025cites this paper
• Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach

  2025cites this paper
• Zanthoxylum bungeanum-derived extracellular vesicles alleviate liver fibrosis via TGF-β1/Smad pathway

  2025cites this paper
• Optimization of CCl4 induced liver fibrosis model in Wistar rats: different doses and time periods

  2025cites this paper
• Identification of MEOX1 as a potential target in metabolic dysfunction-associated steatohepatitis-related liver fibrosis

  2025cites this paper
• Identification and validation of the fibrosis-related molecular subtypes of hepatocellular carcinoma by bioinformatics

  2025cites this paper
• Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease

  2025cites this paper
• Innovative Strategy for Enhanced Delivery of Anti-Fibrotic miR-150 via PDGFR-Targeted Exosomes for Fibrosis Treatment

  2025cites this paper
• Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease

  2025cites this paper
• Fibrotic Changes in Rhegmatogenous Retinal Detachment

  2025cites this paper
• Diamond-Like Carbon Depositing on the Surface of Polylactide Membrane for Prevention of Adhesion Formation During Tendon Repair

  2024cites this paper
• Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy

  2024cites this paper
• Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping

  2024cites this paper
• Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

  2024cites this paper
• Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity

  2024cites this paper
• Mechanistic insight into the hepatoprotective effect of Moringa oleifera Lam leaf extract and telmisartan against carbon tetrachloride-induced liver fibrosis: plausible roles of TGF-β1/SMAD3/SMAD7 and HDAC2/NF-κB/PPARγ pathways

  2024cites this paper
• An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Varroa destructor parasitism and Deformed wing virus infection in honey bees are linked to peroxisome‐induced pathways

  2024cites this paper
• Allium sativum nanovesicles exhibit anti-inflammatory and antifibrotic activity in a bleomycin-induced lung fibrosis model

  2024cites this paper
• Mic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease

  2024cites this paper
• Isolation, Culture, and Characterization of Primary Kidney Fibroblasts from Human Patients with Chronic Antibody-mediated Kidney Transplant Rejection

  2024cites this paper
• Emerging therapeutics for the management of intestinal fibrosis and strictures.

  2024cites this paper
• HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy

  2024cites this paper
• Periostin’s role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma

  2024cites this paper
• Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies

  2024cites this paper
• Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease.

  2024cites this paper
• Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

  2024influential citation
• Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition

  2024cites this paper
• Flavonoids-based nanomedicine for the treatment of liver fibrosis: A recent progress

  2024cites this paper
• The Immune Landscape of Uterine Fibroids as Determined by Mass Cytometry.

  2024cites this paper
• Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

  2024cites this paper
• Epithelial to mesenchymal transition in mammary gland tissue fibrosis and insights into drug therapeutics

  2023cites this paper
• Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids

  2023cites this paper
• Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism

  2023cites this paper
• Mangiferin protects DNase 2 abundance via Nrf2 activation to prevent cytosolic mtDNA accumulation during liver injury.

  2023cites this paper
• DDR1-Induced Paracrine Factors of Hepatocytes Promote HSC Activation and Fibrosis Development.

  2023cites this paper
• Molecular mechanisms of autophagy and implications in liver diseases

  2023cites this paper
• Soluble guanylate cyclase agonist, isoliquiritigenin attenuates renal damage and aortic calcification in a rat model of chronic kidney failure.

  2023cites this paper
• Potential Role of Biopeptides in the Treatment of Idiopathic Pulmonary Fibrosis

  2023cites this paper
• p53 and Myofibroblast Apoptosis in Organ Fibrosis

  2023cites this paper
• Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis

  2023cites this paper
• Effects of exosomes derived from fibroblast cells on skin wound healing in Wistar rats.

  2023cites this paper
• M6P-modified solid lipid nanoparticles loaded with matrine for the treatment of fibrotic liver

  2023cites this paper
• Anti-inflammatory effect of dental pulp stem cells

  2023cites this paper
• Association between fibrosis-related gene polymorphism and long-term allograft outcome in renal transplant recipients

  2023cites this paper
• Serum-deprivation response of ARPE-19 cells; expression patterns relevant to age-related macular degeneration

  2023cites this paper
• Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer

  2023cites this paper
• A New Player in the Mechanobiology of Deep Fascia: Yes-Associated Protein (YAP)

  2023cites this paper
• Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals

  2023cites this paper
• Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration

  2023cites this paper
• Macrophages Serve as Bidirectional Regulators and Potential Therapeutic Targets for Liver Fibrosis

  2023cites this paper
• Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation

  2023cites this paper
• Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.

  2023cites this paper
• Macrophages promote Fibrinogenesis during kidney injury

  2023cites this paper
• The Origin and Fate of Liver Myofibroblasts

  2023cites this paper
• Fibrosis in Liver and Pancreas: a Review on Pathogenic Significance, Diagnostic Options, and Current Management Strategies

  2023cites this paper
• Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers

  2023cites this paper
• Potential Therapeutic Uses of Thalidomide for Pulmonary Fibrosis

  2023cites this paper
• Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis

  2023cites this paper
• Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy

  2022cites this paper
• Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells

  2022cites this paper
• CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway

  2022cites this paper
• Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis

  2022cites this paper
• The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells

  2022cites this paper
• Urethral monopolar cauterization: alternative infravesical obstruction model in male rats

  2022cites this paper
• Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis

  2022cites this paper
• Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models.

  2022cites this paper
• Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis

  2022cites this paper
• Evidence of Renin–Angiotensin System Receptors in Deep Fascia: A Role in Extracellular Matrix Remodeling and Fibrogenesis?

  2022cites this paper
• New insight in the immune mechanisms in hyperuricemia after renal transplantation: a narrative review.

  2022cites this paper
• Quantitative proteomics reveals specific protein regulation of severe hypospadias

  2022cites this paper
• Quantitative and qualitative analysis of pulmonary arterial hypertension fibrosis using wide-field second harmonic generation microscopy

  2022cites this paper
• Function and regulation of GPX4 in the development and progression of fibrotic disease

  2022cites this paper
• Role of Circulating Hematopoietic Fibrocytes in Chronic Hepatitis C Patients Induced Liver Fibrosis

  2022cites this paper
• Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs.

  2022cites this paper
• Xanthohumol Interferes with the Activation of TGF-β Signaling in the Process Leading to Intestinal Fibrosis

  2022cites this paper
• miR-146b-5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1

  2022cites this paper
• Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

  2022cites this paper
• The role of green peas protein hydrolysate in TGF/ SMAD signaling to prevent renal fibrosis

  2022cites this paper
• Comparative Transcriptome Analysis of Superficial and Deep Partial-Thickness Burn Wounds in Yorkshire vs Red Duroc Pigs.

  2022cites this paper
• Modified risk tobacco products and cardiovascular repair: still very smoky.

  2022cites this paper
• Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.

  2022cites this paper
• Decoding liver fibrogenesis with single-cell technologies

  2022cites this paper
• Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

  2022cites this paper
• Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases

  2022cites this paper
• Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis

  2022cites this paper
• Liver fibrosis quantification

  2022influential citation
• Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective

  2022cites this paper
• Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis.

  2022cites this paper